DEVELOPMENT AND SUPPLY AGREEMENT by and between PFIZER, INC. and TREVENA, INC. Dated as of December 15, 2016Development and Supply Agreement • March 7th, 2018 • Trevena Inc • Pharmaceutical preparations • Delaware
THIS DEVELOPMENT AND SUPPLY AGREEMENT (“Agreement”) is made as of this 15th day of December, 2016 (the “Effective Date”) by and between Trevena, Inc., a company formed under the laws of Delaware and having its principal offices at 1018 West 8th Avenue, Suite A, King of Prussia, Pennsylvania 19406 (“Trevena”) and the Pfizer CentreOne group of Pfizer, Inc., a corporation formed under the laws of Delaware and doing business at 275 North Field Drive, Lake Forest, Illinois 60045, on behalf of itself and any one or more of its Affiliates (collectively, “Pfizer”). Pfizer and Trevena collectively shall be referred to as the “Parties” and each as a “Party.”
MASTER COMMERCIAL SUPPLY AGREEMENTMaster Commercial Supply Agreement • March 7th, 2018 • Trevena Inc • Pharmaceutical preparations • Delaware
THIS MASTER COMMERCIAL SUPPLY AGREEMENT (the “Agreement”) is made and entered into this 20th day of October, 2017 (the “Effective Date”), by and between Alcami Corporation, having a place of business at 2320 Scientific Park Drive, Wilmington, NC 28405 (including its wholly-owned subsidiaries, collectively, “Company”), and Trevena, Inc., having a place of business at 955 Chesterbrook Blvd, Suite 200, Chesterbrook, PA 19087 (“Client”). Company and Client, as used herein, may be referred to, collectively, as “Parties” and individually as a “Party”.
